Cannabinoid
An independent research initiative dedicated to advancing scientific understanding of the endocannabinoid system and cannabinoid-based therapies.
Research Areas
The institute’s research spans a wide range of scientific and clinical domains:
- Cannabinoid-based therapies in chronic diseases
- Endocannabinoid system modulation
- Neurodegenerative and psychiatric disorders
- Pain, stress, and anxiety-related conditions
- Epigenetics and immunological mechanisms
Scientific Methods
Research activities include randomized controlled trials, laboratory and animal studies, observational studies, and advanced neuroimaging techniques. These approaches aim to better understand the therapeutic potential and safety of cannabinoids.
Clinical Expertise
ICR along with affiliated clinics offers complementary cannabinoid‑based therapy for individuals with chronic medical conditions, including cancer, persistent pain, rheumatic disorders, and neurological diseases. We also support individuals without a formal diagnosis who seek preventive or wellness‑oriented cannabinoid guidance for stress, sleep, pain, or seasonal health issues.
Our approach integrates conventional medicine with scientifically grounded cannabinoid interventions.
Scientific Research
The institute conducts and supports research in the following areas:
– Therapeutic applications of cannabinoids in chronic diseases
– Medicinal and pharmacological mechanisms of the endocannabinoid system
– Behavioral and psychological effects of cannabis
– Drug interactions and safety profiles and genetic profiling of Cannabinoid receptor and enzyme status
– Clinical and preclinical studies on cannabinoids
– Personalized responses based on age, sex, and biological factors